Detail Information of Genetic Polymorphisms
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0244 Transporter Info | ||||
Gene Name | SLC28A1 | ||||
Protein Name | Concentrative nucleoside transporter 1 | ||||
Gene ID | |||||
UniProt ID | |||||
Genetic Polymorphisms of DT (GPD) | |||||
Genetic Polymorphism | rs2242046 | ||||
Site of GPD | chr15:84935498 (GRCh38.p12) | ||||
GPD Type | SNP | ||||
Allele(s) in dbSNP | G>A / G>T | ||||
Minor Allele Frequency | A=0.2081/1042 (Global) | ||||
Genotype GG | Click to Show/Hide the Full List of Affected Drugs: 1 Drugs in Total | ||||
Gemcitabine | Drug Info | Non-Small-Cell Lung Carcinoma | Correlated with the decreased hematologic toxicity risk in patients (compare with genotypes AA + AG) | [ 1] | |
Genetic Polymorphism | rs2290271 | ||||
Site of GPD | chr15:84904404 (GRCh38.p12) | ||||
GPD Type | SNP | ||||
Allele(s) in dbSNP | A>C | ||||
Minor Allele Frequency | C=0.4383/2195 (Global) | ||||
Allele C | Click to Show/Hide the Full List of Affected Drugs: 3 Drugs in Total | ||||
Daunorubicin | Drug Info | Neoplasm | Irrelevant to the likelihood of cardiotoxicity in patients (compare with Allele A) | [ 2] | |
Doxorubicin | Drug Info | Neoplasm | Irrelevant to the likelihood of cardiotoxicity in patients (compare with Allele A) | [ 2] | |
Anthracyclines | N.A. | Neoplasm | Correlated with the decreased likelihood of cardiotoxicity in patients (compare with Allele A) | [ 3] | |
Genetic Polymorphism | rs2305364 | ||||
Site of GPD | chr15:84909044 (GRCh38.p12) | ||||
GPD Type | SNP | ||||
Allele(s) in dbSNP | T>C | ||||
Allele T | Click to Show/Hide the Full List of Affected Drugs: 3 Drugs in Total | ||||
Daunorubicin | Drug Info | Neoplasm | Irrelevant to the likelihood of cardiotoxicity in patients (compare with allele C) | [ 2] | |
Doxorubicin | Drug Info | Neoplasm | Irrelevant to the likelihood of cardiotoxicity in patients (compare with allele C) | [ 2] | |
Anthracyclines | N.A. | Neoplasm | Correlated with the increased likelihood of cardiotoxicity in patients (compare with allele C) | [ 3] | |
References | |||||
1 | Distribution of gemcitabine pathway genotypes in ethnic Asians and their association with outcome in non-small cell lung cancer patients. Lung Cancer. 2009 Jan;63(1):121-7. | ||||
2 | Validation of variants in SLC28A3 and UGT1A6 as genetic markers predictive of anthracycline-induced cardiotoxicity in children. Pediatr Blood Cancer. 2013 Aug;60(8):1375-81. | ||||
3 | Pharmacogenomic prediction of anthracycline-induced cardiotoxicity in children. J Clin Oncol. 2012 May 1;30(13):1422-8. |
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.